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510a Tuesday, February 23, 2010[Ca2þ]r of triadin-null cells to levels similar to Wt cells, suggesting either an
additional Ca2þ entry pathway, insensitive Cd2þ and La3þ, or an enhanced
Ca2þ release. Inhibition of Ca2þ release by ryanodine resulted in a significant
reduction of [Ca2þ]r in triadin-null cells but not in Wt, indicating that triadin-
null cell also have increased baseline RyR1 channel activity. Western blot anal-
ysis and lipid bilayer studies revealed that calcium channels from triadin-null
cells have reduced FKBP-12 binding and increased subconductance states,
respectively. Accordingly, over expression of FKBP-12.6 caused a significant
reduction in [Ca2þ]r in triadin-nulls but did not affect Wt cells. Overall these
data support the idea that elevated resting free calcium levels observed in tria-
din-null myotubes are the combined effect of at least two things: (i) an increase
in calcium entry mediated by Cd2þ and La3þ sensitive channels, but insensitive
to nifedipine, and (ii) an augmented basal SR calcium release as the result of
enhanced RyR1 channel activity induced by a deficiency in RyR1/FKBP-12
binding.
Supported by NIH Grants 5K01AR054818-02 (to CFP) and 1P01AR044750 (to
PDA).
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The sarcolemmal L-type Ca2þ channel (DHPR), is known to both positively
and negatively regulate RyR1 in skeletal muscle. The mechanism for the neg-
ative control is unknown. To assess this we measured resting intracellular Ca2þ
concentration ([Ca2þ]rest) using Ca
2þ-selective microelectrodes in dysgenic
(MDG) and Wt myotubes. The [Ca2þ]rest in MDG and Wt myotubes were
1585 2.5 nM (mean5 SE, n ¼ 9) and 1175 2.1 nM (n ¼ 10), respectively
(p<0.001). Bastadin 5 (B5), which suppresses the leak state of RyR1, decreased
[Ca2þ]rest to 99 5 0.7 nM (n=16) and 10351.3 nM (n=16) in Wt and MDG
myotubes, respectively. After FK506 treatment, [Ca2þ]rest increased to 139
5 2.4 nM (n=10), 2175 3.0 nM (n=10) in Wt and MDG myotubes, respec-
tively and the addition of B5 in FK506 treated cells had negligible effect:
129 5 1.8 nM (n=10) and 202 5 3.5 nM (n=10) respectively. These experi-
ments clearly show that B5 treatment equalizes the [Ca2þ]rest in all the three
cell types tested while FK506 abolishes its action. To estimate the SR Ca2þ
content, we measured Ca2þ release elicited by 20 mM caffeine, using Fluo5N.
The area under the curve of the Fluo5N signal was ~4 times smaller in MDG
(2552.3 arbitrary units (a.u.), n=69) compared to Wt (10758.5 a.u, n=66)
and B5 increased the Ca2þ release only in MDG cells: 76516 a.u. (n=21)
MDG vs 101512 a.u. (n=60) Wt. These data demonstrate that the negative
control exerted by the DHPR is at least in part due to the ability of the
DHPR to control the percent of RyR1s in the leak state. Supported by NIH/
NIAMS R01AR43140 (to PDA and INP)
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In prior studies others and we found an increase in spontaneous Ca2þ release in
ventricular myocytes isolated from streptozotocin-induced diabetic rat hearts.
To date, molecular mechanisms underlying this phenomenon remains poorly
defined. This study tests the hypothesis that the sensitivity of RyR2 to be acti-
vated by intrinsic modulators is altered during diabetes. Diabetes was induced
in male Sprague-Dawley rats using streptozotocin. Ten weeks after injection,
diabetic rats were divided into two groups: one group was treated with insulin
for two weeks while the other group received no treatment. At the end of this
time, cardiac and myocyte functions were assessed using echocardiography and
high-speed video edge detection. Evoked Ca2þ transients were also assessed
using confocal microscopy. Expression of RyR2 was assessed using RT-PCR
and Western blots, while RyR2 activity and responsiveness to Ca2þ, cADP-ri-
bose and AMP-PCP were assessed using [3H]ryanodine binding and single
channel analyses. After 12 weeks of diabetes, ejection fraction and fraction
shortening were reduced by >25%. Rate of evoked Ca2þ release was slowed
as was the time to peak myocyte contraction. Expression of RyR2 and the total
amount of [3H]ryanodine bound at 200mM Ca2þ were reduced by z 40%.
However, the Kd for ryanodine remained essentially unchanged (5.2nM). Inter-
estingly, in [3H]ryanodine binding and single channel assays, diabetic RyR2was activated to a greater extentby low Ca2þ (0.53 mM and 1 mM), AMP-PCP
(1mM) and cADP-ribose (1 mM). Two-weeks of insulin, initiated after 10
weeks of diabetes, treatment blunted these changes. These new data indicate
that the increase in spontaneous Ca2þ release seen in diabetic myocytes stems
in part from alterations in the responsiveness of RyR2 to activation by intrinsic
ligands. Funded in part by NIH HL085061 and the Nebraska Redox Biology
Center.
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Voltage-dependent modulation of cardiac ryanodine receptors (RyR2) was
studied in planar lipid bilayers. Different earth alkaline cations (M2þ: Mg2þ,
Ca2þ, Sr2þ, Ba2þ) were utilized as current carriers. When added to the cytosolic
surface of the channels, Ca2þ (EC50 ~2mM) or Sr
2þ (EC50 ~20mM) interacted
with cytosolic high affinity (HA) sites and activated the channels. Neither
Mg2þ nor Ba2þ activated RyR2 but only Mg2þ interfered with Ca2þ/Sr2þ ac-
tion. Fully activated RyR2 (100-200mM cytosolic Ca2þ) were inhibited with
low affinity (LA) by all M2þ (similar IC50, ranging 3.6-5.7mM) suggesting
that LA inhibitory sites do not distinguish M2þ identity. We found that
RyR2 were much more active with lumenal Ca2þ/Sr2þ versus lumenal Ba2þ/
Mg2þ. However increasing lumenal/cytosolic M2þ flux by increasing lu-
menal holding voltage (Vm) never increased open probability (Po). In contrast,
increasing Vm decreased Po in half of the RyR2 exposed to lumenal Ca2þ/Sr2þ
and in all RyR2 exposed to lumenal Ba2þ/Mg2. This suggests that lumenal flux
does not reach HA but LA sites. An effect of Vm is evident in all channels dis-
playing modal gating (low and high Po mode) but not in RyR2 where high Po
dominates. Indeed, high Po mode is much more abundant with lumenal Ca2þ/
Sr2þ. Moreover, increasing cytosolic Ca2þ activated all channels and removed
the effect of Vm. In summary, modulation of RyR2 gating by M2þ flux is com-
plex and seems to reflect lumenal M2þ-dependent stabilization of high Po and
low Po mode (the latter being voltage-dependent). Supported by NIH R01
GM078665 to JAC.
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Ryanodine receptors (RyRs) are a family of Ca2þ release channels found in
intracellular Ca2þ storage/release organelles and participate in a variety of
important Ca2þ signaling phenomena. Here, we set to clone and sequence
full-length cDNA encoding the type 2 RyR (RyR2) from smooth muscle cells
of Rattus norvegicus cerebral arteries. Middle cerebral and basilar arteries
were isolated and de-endothelized, and total RNA was purified for RT-PCR.
RyR2 cDNA was divided in two parts of similar size; 5’ segment: 1-7486
bp, and 3’ segment: 7487-14862 bp. Specific primers were designed to obtain
both 5’ and 3’-terminals. Following insertion of both terminals in the mamma-
lian expression vector pCI-neo, we characterized several clones by restriction
analysis, and confirmed the full-length cDNA sequence by automated se-
quencing. The rat cerebral artery smooth muscle RyR2 cDNA contains
14862 bp and encodes a deduced protein of 4953 amino acids with a Mr of
562451.3 Da. Nucleotide blast analysis indicates that the cerebral artery
smooth muscle RyR2 shows 100% identity with recombinant RyR2 cloned
from rat cardiac muscle (Accession NM_032078). RyR2 cDNA expression
was determined after transfection of HEK293 cells with the insert into the
pCMV6-AN-tagGFP vector. Membrane insertion of cerebral artery myocyte
RyR2 was determined by immunolabeling with polyclonal antibodies. To
our knowledge, this is the first time that a RyR is cloned from rat cerebral
artery smooth muscle, its functional characteristics being currently studied.
Supported by Grant AA11560 (AMD).
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Several lines of evidence exist to support the proposal that RyR2 contains
a pore composed of structural elements analogous to the pore forming regions
(PFR) of Kþ channels. Our analogy model, constructed using the bacterial
